Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inari Medical, Inc.
  6. News
  7. Summary
    NARI   US45332Y1091

INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
71.14 USD   +2.74%
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/21Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SVB Leerink Adjusts Inari Medical's Price Target to $95 from $85, Maintains Outperform Rating

02/24/2022 | 12:44pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about INARI MEDICAL, INC.
06/24BTIG Adjusts Inari Medical's Price Target to $100 from $130, Keeps Buy Rating
MT
06/21Inari Medical's Shares Rise After Piper Sandler Initiates Coverage
MT
06/21Piper Sandler Starts Inari Medical at Overweight With $100 Price Target
MT
06/17INSIDER SELL : Inari Medical
MT
06/09INSIDER SELL : Inari Medical
MT
06/09Certain Options of Inari Medical, Inc. are subject to a Lock-Up Agreement Ending on 9-J..
CI
06/09Certain Restricted Stock Units of Inari Medical, Inc. are subject to a Lock-Up Agreemen..
CI
06/09Certain Common Stock of Inari Medical, Inc. are subject to a Lock-Up Agreement Ending o..
CI
06/08INSIDER SELL : Inari Medical
MT
06/07OKAMI MEDICAL ANNOUNCES FDA 510(k) CLEARANCE OF THE LOBO-7 and LOBO-9 VASCULAR OCCLUDER..
PR
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -38,5 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -95,6x
Yield 2022 -
Capitalization 3 779 M 3 779 M -
EV / Sales 2022 9,49x
EV / Sales 2023 7,94x
Nbr of Employees 800
Free-Float 84,9%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 71,14 $
Average target price 105,00 $
Spread / Average Target 47,6%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-22.06%3 779
NOVOCURE LIMITED0.69%7 907
MASIMO CORPORATION-53.68%7 693
SHOCKWAVE MEDICAL, INC.10.86%7 076
GETINGE AB-41.69%6 197
PENUMBRA, INC.-54.15%4 964